NATUS MEDICAL INC company info

CIK 878526
IRS Number 770154833
State of incorporation DE
Business address 6701 KOLL CENTER PARKWAY, SUITE 120
None
PLEASANTON
CA
94566
Mail address 6701 KOLL CENTER PARKWAY, SUITE 120
None
PLEASANTON
CA
94566

Short summary

NATUS MEDICAL INC is a California company, with head office located at 6701 Koll Center Parkway, Suite 120 Pleasanton, California 94566. In 2018 the company owned a total of 638.56 million USD worth of assets, including 273.98 million USD worth of current assets. 2017 was the year when the company amassed the most assets.

NATUS MEDICAL INC Income Statement

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Cost of Goods and Services Sold 144.63213.38217.95
Gross Profit 100.35129.80131.29163.33202.41214.39227.54234.93281.21304.02
Research and development 16.7321.2825.5829.9732.0730.1030.4333.4451.8261.48
Operating Expenses 85.02111.87141.62158.21167.75168.54174.06179.67272.50328.58
Operating Income (Loss) 15.3317.93-10.335.1134.6645.8553.4755.268.72-24.56
Interest expense 0.130.270.491.680.440.350.435.086.79
Other Nonoperating Income (Expense) 0.500.15-0.180.340.510.680.120.08-0.44
Income Tax Expense (Benefit) 5.705.800.770.458.8013.5314.4912.3125.44-9.33
Net income 11.3811.94-11.183.8223.1532.4837.9242.59-20.29-22.94

NATUS MEDICAL INC Balance Sheet

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Cash and cash equivalents 56.9238.9637.7516.9628.9156.0273.2496.2880.3054.9153.42
Available-for-sale Securities, Current 82.47247.5788.95
Accounts Receivable, Net, Current 53.7758.1487.5676.9183.3493.10114.06122.97110.90
Inventories 39.4025.6938.9135.5044.8743.6269.2876.6382.87
Deferred income taxes 3.865.038.639.0611.470
Property, Plant and Equipment, Gross 49.9253.3247.5146.5848.4154.8159.3768.09
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 23.0827.4826.4028.2331.2333.9637.7241.81
Goodwill 96.8580.3997.36100.93108.52110.86176.72163.55147.39
Intangible Assets, Net (Excluding Goodwill) 67.7065.72103.1898.5390.2781.31144.11162.56132.21
Other Assets, Noncurrent 4.696.918.459.298.3618.0119.2118.8620.56
Total assets 333.64348.23404.81419.71453.86486.09662.59663.64638.56
Current assets 139.58168.37169.98189.86228.36245.93286.98286.73273.98
Accounts payable 16.9515.8125.8124.9819.2718.8426.7624.0525.10
Taxes Payable, Current 2.125.874.819.214.714.1611.009.39
Total current liabilities 42.3957.5071.9570.2366.3777.4086.2495.82161.31
Long-term Debt, Excluding Current Maturities 0.6617.2840.3860109.50119.3864.52
Long-term Debt 25.8050.5616.4100109.50119.38100
Deferred Revenue, Noncurrent 1.221.171.121.541.401.894.044.34
Deferred income taxes 7.198.989.3410.778.673.8431.0418.948.47
Total liabilities 58.5188.97125.4589.3080.0989.88236.10256.10270.86
Common Stock, Value, Issued 263.68270.19281.87306.13321.71311.63314.63321.30335.35
Retained Earnings (Accumulated Deficit) 6.9923.527.9719.1048.5187.34125.87144.72119.4773.59
Accumulated Other Comprehensive Income (Loss), Net of Tax -12.08-18.90-21.61-24.22-35.28-41.27-32.86-33.23-41.24

NATUS MEDICAL INC Cash Flow

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Net income 11.3811.94-11.183.8223.1532.4837.9242.59-20.29-22.94
Depreciation 3.6044.604.704.304.203.704.106
Amortization of Intangible Assets 5.456.188.068.163.037.458.9819.1722.59
Depreciation and amortization 7.889.1010.1912.6212.8511.7615.9916.8830.1033.86
Deferred Income Tax Expense (Benefit) 1.65-3.86-3.981.03-0.94-3.24-2.061.49-13.13
Accounts receivable -0.683.23-0.1622.03-9.362.4315.27-19.7230.475.20
Inventories -0.038.18-3.74-5.262.302.0212.237.67-7.587.44
Accounts payable 0.46-5.47-7.0611.31-1.39-7.653.27-4.97-1.394.11
Deferred revenue -0.150.722.111.71-0.77-0.78-1.1213.88-7.232.08
Net Cash Provided by (Used in) Operating Activities 26.5911.4622.7519.3936.8042.1436.8572.6919.7333.02
Payments to Acquire Property, Plant, and Equipment 2.614.154.187.341.834.244.073.194.077.88
Payments to Acquire Businesses, Net of Cash Acquired 55.1218.604.9314.2815.85190.89-0.15
Payments to Acquire Intangible Assets 1.000.340.835.091.881.481.130.2100.67
Net Cash Provided by (Used in) Investing Activities -51.80-17.91-19.37-62.46-22.30-10.65-19.48-53.26-160.94-8.39
Proceeds from Issuance of Long-term Debt 2535.3800140600
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 4.265.406.476.425.926.066.959.019.4517.00
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 4.265.406.476.425.926.066.959.019.4517.00
Payments for Repurchase of Common Stock 04.6311.5319.292.275.63
Net Cash Provided by (Used in) Financing Activities 0.491.701.7033.4217.25-20.910.83118.425.83-49.51
Cash and Cash Equivalents, Period Increase (Decrease) -24.33-4.204.43-9.7633.0510.4515.91131.08-124.60-32.58